Safety of casirivimab/imdevimab administration in a SARS-CoV-2 positive maintenance dialysis patient in Japan

Controlling excessive cytokine secretion is a crucial therapeutic strategy for managing coronavirus disease 2019 (COVID-19). Patients on dialysis are at a high risk of severe disease, given abnormal immune responses that can lead to prolonged inflammation. Moreover, patients undergoing dialysis have...

Descripción completa

Detalles Bibliográficos
Autores principales: Terakawa, Kanako, Katagiri, Daisuke, Shimada, Keiki, Sato, Lubna, Takano, Hideki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742683/
https://www.ncbi.nlm.nih.gov/pubmed/35000134
http://dx.doi.org/10.1007/s13730-021-00671-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742683/
https://www.ncbi.nlm.nih.gov/pubmed/35000134
http://dx.doi.org/10.1007/s13730-021-00671-1

Ejemplares similares